<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02730910</url>
  </required_header>
  <id_info>
    <org_study_id>UGuelph</org_study_id>
    <nct_id>NCT02730910</nct_id>
  </id_info>
  <brief_title>Anthocyanin &amp; Phenolic Acids Bioavailability &amp; Antioxidant Capacity After Consumption of Purple Wheat Products in Adults</brief_title>
  <official_title>Bioavailability of Anthocyanins and Phenolic Acids and Changes in Blood Antioxidant Capacity After Consumption of Purple Wheat Anthocyanin-enriched Crackers and Granola Bars by Healthy Adult Participants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Guelph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Guelph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine the bioavailability of anthocyanins and phenolic compounds from two&#xD;
      purple wheat products, i.e. bran-enriched wholegrain purple wheat crackers and bran-enriched&#xD;
      wholegrain purple wheat granola bars. Crackers are an example of a baked/ processed product.&#xD;
      The purple wheat granola bars are an example of a food product that requires much less&#xD;
      intensive preparation and cooking, compared to the crackers. A comparison of bioavailability&#xD;
      between these two products should provide insights about how different processes and food&#xD;
      matrix influence anthocyanin bioavailability and metabolism.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will determine the bioavailability of anthocyanins and phenolic compounds from two&#xD;
      purple wheat products, i.e. bran-enriched wholegrain purple wheat crackers and bran-enriched&#xD;
      wholegrain purple wheat granola bars. Crackers are an example of a baked/ processed product.&#xD;
      The purple wheat granola bars are an example of a food product that requires much less&#xD;
      intensive preparation and cooking, compared to the crackers. A comparison of bioavailability&#xD;
      between these two products should provide insights about how different processes and food&#xD;
      matrix influence anthocyanin bioavailability and metabolism. The study is a crossover&#xD;
      investigation with 8 men and 8 women who will adhere to a low anthocyanin and low phenolic&#xD;
      diet for the duration and complete 2 postprandial study visits where, in random order, they&#xD;
      will consume either the crackers or granola bars. Blood and urine will be collected at&#xD;
      baseline and postprandially for the analysis of anthocyanins and their metabolites and&#xD;
      phenolic acids and determination of antioxidant capacity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">March 1, 2017</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma concentrations of anthocyanin metabolites</measure>
    <time_frame>0-8 hours (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma concentrations of phenolic acids</measure>
    <time_frame>0-8 hours (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma antioxidant capacity</measure>
    <time_frame>0-8 hours (0, 2, 4, 6, 8)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary concentrations of phenolic acids</measure>
    <time_frame>0-8 hours (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary concentrations of anthocyanin metabolites</measure>
    <time_frame>0-8 hours (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Purple Wheat Crackers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bran-enriched purple wheat wholegrain crackers served in 120 g portion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Purple Wheat Granola Bars</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bran-enriched purple wheat wholegrain granola bars served in 160 g portion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Purple Wheat Crackers</intervention_name>
    <description>Whole grain crackers manufactured with purple wheat</description>
    <arm_group_label>Purple Wheat Crackers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Purple Wheat Granola Bars</intervention_name>
    <description>Whole grain granola bars manufactured with purple wheat</description>
    <arm_group_label>Purple Wheat Granola Bars</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI of 18 - 27 kg/m2&#xD;
&#xD;
          -  Generally healthy as determined by screening questionnaire&#xD;
&#xD;
          -  Non-smoking&#xD;
&#xD;
          -  Non to moderate alcohol drinkers (Typical consumption less than 5 drinks per sitting&#xD;
             and no more than 14 per week)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breast-feeding females&#xD;
&#xD;
          -  History of any major disease or medical condition, including any disorder of the&#xD;
             gastrointestinal system or food intolerances&#xD;
&#xD;
          -  Taking any prescription medications (including hormonal contraceptives) or over the&#xD;
             counter medications prescribed by a medical professional&#xD;
&#xD;
          -  Taking any natural health products or dietary supplements, other than a multivitamin&#xD;
             low in anthocyanins and phenolic acids&#xD;
&#xD;
          -  Oral antibiotic use in the past 3 months&#xD;
&#xD;
          -  Any food allergies, and any anaphylactic or life-threatening allergies - food or&#xD;
             otherwise&#xD;
&#xD;
          -  Smokers or use of recreational drugs (marijuana, magic mushrooms, etc)&#xD;
&#xD;
          -  Elite or training athletes&#xD;
&#xD;
          -  Following a vegan or vegetarian diet&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Human Nutraceutical Research Unit, University of Guelph</name>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <zip>N1G2W1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>January 21, 2016</study_first_submitted>
  <study_first_submitted_qc>April 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2016</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Guelph</investigator_affiliation>
    <investigator_full_name>Amanda Wright, Ph.D.</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Bioavailability</keyword>
  <keyword>adults</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Through peer reviewed publications</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

